Ledger.Open graph →
SEC Form D · filed July 1, 2014

BRAINSTORM CELL THERAPEUTICS INC

Offering
$10.5M
Sold
$10.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Liat Sossover · NEW YORK, NYExecAlon Pinkas · NEW YORK, NYDirectorMalcolm S. Taub · NEW YORK, NYDirectorChaim S. Lebovits · NEW YORK, NYExecRobert Shorr · NEW YORK, NYDirectorIrit Arbel · NEW YORK, NYDirectorMordechai S. Friedman · NEW YORK, NYDirectorChen Schor · NEW YORK, NYDirectorAnthony S. Fiorino · NEW YORK, NYExecPaul E. Vredenburg · LAKE MARY, FLDirectorEric E. Anderson · LAKE MARY, FLDirectorStanley K. Kinnett Ii · LAKE MARY, FLDirectorDean J. Curtis · LAKE MARY, FLDirectorWalter L. Smith · LAKE MARY, FLExecRichard G. Hunter · Valdosta, GADirectorRonald R. Holmes · Valdosta, GADirectorAmanda H. Holmes · Valdosta, GAExecAnthony S. Fiorino · Hackensack, NJExecUri S. Yablonka · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗